The US FDA has approved a new medicine for tuberculosis which shortens and enhances treatment for difficult-to-attend cases, a major issue in several poor nations.
This is the first ever tuberculosis drug by non-profit group called TB Alliance. With the help of government agencies and charities, the group successfully developed pretomanid.
The FDA approved the pill on Wednesday for use along with 2 other antibiotics. Several years of ineffective and incomplete treatment has caused TB strains which are not just drug-resistant but can’t be killed using the standard medicines.
In a major study, the 3-pill combination successfully cured around 90% of the patients suffering from extreme drug-resistant tuberculosis, generally within six months. In fact, the patients who were infected with HIV also fared well. Pretomanid seemed to help stop the patients from commuting the fatal bacterial infection just after some days of treatment.
So far, the bet tuberculosis treatment option cured around 2/3 patients, took between 18-30 months as well as needed around 8 different kinds of pills and shots. Many patients die or do not complete treatment, as per Mel Spigelman, CEO, TB Alliance.
Notably, around 1.6mn die due to tuberculosis annually. The disease spreads via droplets, when a person infected with tuberculosis coughs or sneezes.